EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Physician and Software Assessed Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer

Anna Okabe, Wai Lone J Ho, May Lin Tao, Jason C Ye

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2025.07.006 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Anna Okabe und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, California Northstate University, Sacramento, CA. Hauptthemen laut MEDLINE: Breast Neoplasms, Software. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, University of Southern California, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study aims to compare the cosmetic outcomes in early-stage breast cancer patients treated with whole breast irradiation (WBI) or partial-breast irradiation (PBI), using both subjective and objective tools, to assess clinical factors contributing to cosmesis scores, and to compare radiation toxicity outcomes. METHODS: Breast cosmesis was scored by using the physician-rated Harvard cosmesis scale at the time of consultation and at each follow-up visit and objectively using the BCCT.core software on standardized photographs. RESULTS: Ninety-nine patients received WBI, and thirty-six received PBI. 91% of patients treated with WBI and 86.1% with PBI scored excellent/good by physician ratings at follow-up vs. 68.4% and 72.2 % by BCCT.core software. Agreement between both tools was low (κ = 0.057 for WBI patients and κ = 0.012 for PBI patients). There was less than a 15% decline in physician-rated cosmetic scores for either WBI or PBI patients, but a 27.3% decline for WBI patients by BCCT.core software scoring. There was no association of prone vs. supine position, tumor bed boost, fractionation scheme, or addition of regional nodal irradiation with long-term cosmesis scores determined by either assessment tool, except for oncoplastic surgery which was associated with a higher score. CONCLUSIONS: Breast cosmesis scores after either WBI or PBI are favorable; however, the agreement between physician rating and the BCCT.core software is poor. The BCCT.core software was more likely to indicate a decline in cosmetic results over time. Surgical outcomes may be the most impactful clinical factor in predicting long-term breast cosmesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSoftwareHumansFemaleMiddle AgedAgedAdultEstheticsFollow-Up StudiesPhysiciansBreastTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

Accelerated Partial breast irradiation (APBI)Adjuvant radiotherapyBreast conserving therapyToxicityWhole breast irradiation (WBI)

Autor:innen und Institutionen

  • College of Medicine, California Northstate University, Sacramento, CA.
  • Morsani College of Medicine, University of South Florida, Tampa, FL.
  • Department of Radiation Oncology, USC Keck School of Medicine, Los Angeles, CA.
  • Department of Radiation Oncology, USC Keck School of Medicine, Los Angeles, CA. Electronic address: jason.ye@med.usc.edu.

Förderung

  • NCI NIH HHS
  • University of Southern California
  • National Cancer Institute

Zitieren

APA

Okabe, A., Ho, W. L. J., Tao, M. L., & Ye, J. C. (2026). Physician and Software Assessed Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.07.006

Vancouver

Okabe A, Ho WLJ, Tao ML, Ye JC. Physician and Software Assessed Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.07.006

BibTeX
@article{Okabe2026,
  author = {Okabe, Anna and Ho, Wai Lone J and Tao, May Lin and Ye, Jason C},
  title = {Physician and Software Assessed Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2025.07.006}
}
Kostenlos starten →